|
Oncologists, nurse practitioners, nurses, physician assistants, and other clinicians who specialize in oncology and management of patients with breast cancer
Breast cancer, HER2+, immunohistochemistry, in-situ hybridization, targeted treatment, shared decision-making
1. | Utilize the updated ASCO/CAP 2013 guidelines and the most recent NCCN guidelines for breast cancer to improve detection and classification of HER2 status | 2. | Apply current efficacy and safety data to select targeted treatments that improve outcomes for patients with HER2-positive breast cancer |
3. | Apply current guideline-recommended neoadjuvant and adjuvant treatments and appropriate treatment sequencing strategies for patients with HER2-positive breast cancer | 4. | Effectively engage patients with HER2-positive breast cancer in their healthcare by implementing effective shared decision-making strategies |
1. | Utilize the updated ASCO/CAP 2013 guidelines and the most recent NCCN guidelines for breast cancer to improve detection and classification of HER2 status |
2. | Apply current efficacy and safety data to select targeted treatments that improve outcomes for patients with HER2-positive breast cancer |
3. | Apply current guideline-recommended neoadjuvant and adjuvant treatments and appropriate treatment sequencing strategies for patients with HER2-positive breast cancer |
4. | Effectively engage patients with HER2-positive breast cancer in their healthcare by implementing effective shared decision-making strategies |
PHYSICIAN CONTINUING MEDICAL EDUCATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Supported Browsers: Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above. |